Skip to content

PreventIT enhanced Lifestyle-integrated Functional Exercise programme pilot study

PreventIT enhanced Lifestyle-integrated Functional Exercise programme pilot study - PreventIT eLiFE pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43240
Enrollment
5
Registered
2016-11-02
Start date
2016-11-09
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatrische aandoeningen, functieverlies gerontology old age

Interventions

The eLiFE intervention is a lifestyle-integrated functional exercise programme adapted to young older adults at the age of 60-70 years delivered as an ICT-based intervention (smartphone and smartwat
Elderly
Exercise
Physical activity
Risk prevention

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: We will include community dwelling adults between 60 and 70 years of age. Only participants with ability to walk 500 metres without walking aids will be included.

Exclusion criteria

Exclusion criteria: Exclusion criteria include cognitive impairment (Montreal Cognitive Assessment, MOCA *24 points) and self-reported cardiovascular, pulmonary, neurological, and mental disease where exercise is contraindicated, any changes in health condition the past 6 months (stroke, cancer in need of treatment, severe neurological diseases that affect physical function, COPD (Gold 3 and 4), and heart failure (NYHA 3 and 4)). The target population of eLiFE is not the most fit of the young older adults. Excluded are therefore those who are attending organised exercise classes more than twice a week and/or those who are exercising more than 1 hour on their own each week.

Design outcomes

Primary

MeasureTime frame
Semi-structured questionnaire, focus group and workshop for evaluating usability and feasibility of eLiFE.

Secondary

MeasureTime frame
Late-Life Function and Disability Instrument.

Countries

Germany, Netherlands, Norway

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)